• Health Current Events

    Backed Health Plan, Democrats Take Aim

    LONDON A trial of AstraZeneca’s key immunotherapy drug durvalumab confirmed it reduced disease progression in lung most cancers sufferers, sending the corporate’s shares higher and giving it a lead over rivals because it seeks to remodel its oncology business. Consider…